Author

Alisyn Retos Bourque

Georgia Institute of TechnologyORCID 0000-0001-9075-4559Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Organism:E. coli· 1

Frequent Co-Authors

M. G. FinniD· 2 shared Stephen Nick HousleyiD· 2 shared Amina Maria Alvarez Barkane· 1 shared Anton V. BryksiniD· 1 shared Aref ValipouriD· 1 shared Carolina HernándeziD· 1 shared Elisa Schrader EcheverriiD· 1 shared Isabel PanickeriD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. G. FinnORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioengineeringbioRxivPreprintApr 16, 2026

Integrated Framework for Multiscale Microvascular Models

Aref Valipour, Alisyn Retos Bourque, Stephen Nick Housley

The paper introduces an integrative framework for generating bio-informed microvascular models that unify in silico and in vitro applications, demonstrating faster and more accurate simulations of vascular networks.

DOI 10.64898/2026.04.13.718340

deep learningstatistical model

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedJan 7, 2026

Tumor Agnostic Drug Delivery with Self-Agglomerating Nanohydrogels (SANGs)

Stephen Nick Housley, Alisyn Retos Bourque, Lilya V. Matyunina…·M. G. Finn

This paper develops a tumor-agnostic nanohydrogel (SANGs) platform for RNAi delivery, showing effective oncogene suppression and safety across species.

6 citationstop 2%

mouserat

𝕏 PostBluesky

ImmunologyACS NanoPeer-reviewedJul 23, 2024

Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing

Sonia Bhattacharya, Matthew C. Jenkins, Parisa Keshavarz‐Joud…·M. G. Finn

This paper develops a vaccine strategy using immunologically orthogonal protein nanoparticles to focus antibody responses on a specific SARS-CoV-2 RBD epitope.

16 citationstop 4%

humanE. coli

𝕏 PostBluesky